Central Fund of Canada Limited (USA) 

(Public, AMEX:CEF)   Watch this stock   
Find more results for CEF)

Key stats and ratios

Q4 (Oct '09) 2009
Net profit margin 99.41% 99.15%
Operating margin 99.41% 99.15%
EBITD margin - -
Return on average assets 55.13% 40.56%
Return on average equity 55.19% 40.63%

Address

Suite 805, 1323 15th Avenue S.W.,
Calgary, AB T3C 0X8
Canada
+1-403-2285861 (Phone)
+1-403-2282222 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

Central Fund of Canada Limited (USA) discussions

  View all discussions »

Description

Central Fund of Canada Limited (Central Fund) is an investment holding company. The Company is a specialized, passive holding company with most of its assets held in gold and silver bullion. Central Fund’s purpose is to hold gold and silver bullion on a secure basis for the convenience of investors in the shares of Central Fund. During the fiscal year ended October 31, 2009 (fiscal 2009), Central Fund’s net assets consisted of unencumbered and segregated, passive, long-term holdings of gold and silver bullion. The Company holds about 99.3% interest in gold bullion and 99.6% in the silver bullion, primarily in bar forms.

Officers and directors

Philip M. Spicer
Chairman of the Board
Age: 72
Bio & Compensation - Reuters
J. C. Stefan Spicer
President, Chief Executive Officer, Director
Age: 44
Bio & Compensation - Reuters
Dale R. Spackman QC
Vice Chairman of the Board
Age: 55
Bio & Compensation - Reuters
Catherine A. Spackman
Chief Financial Officer, Treasurer
Bio & Compensation - Reuters
John S. Elder QC
Secretary, Director
Age: 73
Bio & Compensation - Reuters
Teresa E. Poper
Assistant Treasurer
Bio & Compensation - Reuters
Douglas E. Heagle
Lead Director
Age: 79
Bio & Compensation - Reuters
Ian M. T. McAvity
Director
Age: 67
Bio & Compensation - Reuters
Michael A. Parente
Director
Age: 52
Bio & Compensation - Reuters
Robert R. Sale
Director
Age: 75
Bio & Compensation - Reuters